Children and young people’s cancers become focus of pioneering research in ¾ÅÉ«ÊÓƵ
10 March 2026
Children and young people diagnosed with aggressive cancers could benefit from a pioneering project supported by ¾ÅÉ«ÊÓƵ researchers to create new treatments.
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
15 December 2025
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment, or that has relapsed, may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial.
¾ÅÉ«ÊÓƵ scientists awarded Blood Cancer UK grant to develop new leukaemia immunotherapy
11 September 2025
A team of interdisciplinary researchers at the ¾ÅÉ«ÊÓƵ have been awarded a major new grant from Blood Cancer UK to develop a pioneering T cell therapy for acute myeloid leukaemia (AML), one of the most aggressive forms of blood cancer.
Professor Sally Ward wins international prize for breakthroughs in antibody therapies
16 July 2025
Professor Sally Ward, Director of Translational Research at the Centre for Cancer Immunology (CCI) within the ¾ÅÉ«ÊÓƵ’s Faculty of Medicine, has been awarded the International Society of Molecular Recognition Award in Affinity Technology
